FI963719A - Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista - Google Patents

Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista Download PDF

Info

Publication number
FI963719A
FI963719A FI963719A FI963719A FI963719A FI 963719 A FI963719 A FI 963719A FI 963719 A FI963719 A FI 963719A FI 963719 A FI963719 A FI 963719A FI 963719 A FI963719 A FI 963719A
Authority
FI
Finland
Prior art keywords
fractions
proteins
human plasma
plasma fractionation
prepn
Prior art date
Application number
FI963719A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI963719A0 (fi
Inventor
Hanspeter Amstutz
Peter G Lerch
Jean-Jacques Morgenthaler
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of FI963719A0 publication Critical patent/FI963719A0/fi
Publication of FI963719A publication Critical patent/FI963719A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
FI963719A 1995-09-22 1996-09-19 Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista FI963719A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810596A EP0764658B1 (de) 1995-09-22 1995-09-22 Verfahren zur Gewinnung von Immunglobulinen aus Fraktionen, die bei der Fraktionierung von menschlichem Blutplasma entstehen

Publications (2)

Publication Number Publication Date
FI963719A0 FI963719A0 (fi) 1996-09-19
FI963719A true FI963719A (fi) 1997-03-23

Family

ID=8221797

Family Applications (1)

Application Number Title Priority Date Filing Date
FI963719A FI963719A (fi) 1995-09-22 1996-09-19 Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista

Country Status (21)

Country Link
EP (1) EP0764658B1 (ko)
JP (1) JP2952572B2 (ko)
KR (1) KR100236762B1 (ko)
CN (1) CN1089609C (ko)
AT (1) ATE211486T1 (ko)
AU (1) AU715427B2 (ko)
BR (1) BR9603826A (ko)
CA (1) CA2185617A1 (ko)
CZ (1) CZ286885B6 (ko)
DE (1) DE59509979D1 (ko)
DK (1) DK0764658T3 (ko)
ES (1) ES2170788T3 (ko)
FI (1) FI963719A (ko)
HU (1) HUP9602570A3 (ko)
MX (1) MX9604256A (ko)
NO (1) NO963952L (ko)
NZ (1) NZ299394A (ko)
PL (1) PL316126A1 (ko)
PT (1) PT764658E (ko)
RO (1) RO117921B1 (ko)
RU (1) RU2157240C2 (ko)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293119B1 (it) * 1997-06-12 1999-02-11 Mini Ricerca Scient Tecnolog Processo per la separazione di immunoglobuline specifiche da plasma standard e loro utilizzo per trattamenti terapeutici
EP0911037B2 (en) 1997-10-23 2007-06-13 Mitsubishi Pharma Corporation Room temperature storable immunoglobulin preparation for intravenous injection
BRPI0514435B8 (pt) * 2004-08-20 2021-05-25 American Nat Red Cross isolamento sequêncial de proteínas e esquemas de purificação através de cromatografia por afinidade
EP2233499A1 (en) * 2009-03-26 2010-09-29 CSL Behring AG Antibody composition with altered Fab sialylation
US20100322943A1 (en) * 2009-06-17 2010-12-23 Thomas Cantor Therapeutic and diagnostic affinity purified specific polyclonal antibodies
ITRM20090558A1 (it) * 2009-11-03 2011-05-04 Michele Pitaro Procedimento per la produzione di immunoglobuline estratte da plasma umano ad uso terapeutico neutralizzanti il virus di epstein barr e farmaco contenente dette immunoglobuline
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
SG187599A1 (en) * 2010-07-23 2013-03-28 Baxter Int Manufacture of inter -alpha - inhibitor proteins (iaip) from plasma
ES2531459B1 (es) * 2013-06-10 2015-12-28 Antonio VILA SANJURJO Método para la separación física de "traductomas" convolucionados
FR3018450B1 (fr) * 2014-03-11 2016-04-15 Lab Francais Du Fractionnement Procede de preparation de proteines plasmatiques humaines
KR20150115639A (ko) * 2014-04-04 2015-10-14 전숙영 치료용 면역글로불린 제제 제조에 사용되는 산성 완충액, 이를 이용한 치료용 면역글로불린 제제 제조방법 및 이 제조방법으로 제조된 치료용 면역글로불린 제제
GB201413227D0 (en) 2014-07-25 2014-09-10 Bioproducts Lab Ltd Process

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4232004A (en) * 1977-09-21 1980-11-04 American National Red Cross Antibody-specific solid phase immunoadsorbent, preparation thereof, and antibody purification therewith
DE3516119A1 (de) * 1985-05-04 1986-11-06 Biotest Pharma GmbH, 6000 Frankfurt Polyvalentes hyperimmunglobulin-praeparat
IL90281A (en) * 1988-06-06 1994-10-07 Miles Inc Preparations containing MGI antibodies

Also Published As

Publication number Publication date
JP2952572B2 (ja) 1999-09-27
CN1089609C (zh) 2002-08-28
ES2170788T3 (es) 2002-08-16
KR100236762B1 (ko) 2000-01-15
NO963952D0 (no) 1996-09-20
DE59509979D1 (de) 2002-02-07
CZ274896A3 (en) 1997-04-16
DK0764658T3 (da) 2002-04-22
HUP9602570A3 (en) 1998-01-28
CN1153063A (zh) 1997-07-02
ATE211486T1 (de) 2002-01-15
BR9603826A (pt) 1998-06-02
JPH09124508A (ja) 1997-05-13
RO117921B1 (ro) 2002-09-30
AU715427B2 (en) 2000-02-03
KR970015745A (ko) 1997-04-28
NO963952L (no) 1997-03-24
HU9602570D0 (en) 1996-11-28
CA2185617A1 (en) 1997-03-23
HUP9602570A2 (en) 1997-08-28
EP0764658B1 (de) 2002-01-02
EP0764658A1 (de) 1997-03-26
CZ286885B6 (en) 2000-07-12
NZ299394A (en) 1997-12-19
PL316126A1 (en) 1997-04-01
AU6572596A (en) 1997-04-10
RU2157240C2 (ru) 2000-10-10
MX9604256A (es) 1998-04-30
FI963719A0 (fi) 1996-09-19
PT764658E (pt) 2002-06-28

Similar Documents

Publication Publication Date Title
NO913186L (no) Fremgangsmaate for anvendelse og syntese av peptider.
KR950700779A (ko) 단백질의 정제방법(Protein purification)
FI963719A (fi) Menetelmä immunoglobuliinien ottamiseksi talteen ihmisen veriplasman fraktioinnissa syntyvistä fraktioista
ES2106195T3 (es) Anticuerpo igg aglicosilado anti cd3.
WO2003059935A3 (en) Methods for purifying protein
MX9603637A (es) Purificacion de anticuerpo.
NZ310847A (en) High affinity human monoclonal antibodies specific for rsv fusion protein
CA2006865A1 (en) Humanized immunoglobulins and their production and use
SE9304060D0 (sv) Sätt att selektera specifika bakteriofager
MX9307316A (es) Proteinas
DE3484673D1 (de) Digitalis-antikoerper, verfahren zu ihrer herstellung und ihre verwendung zur therapie von digitalis-intoxikationen.
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
GB8910263D0 (en) Monoclonal antibodies specific for an immunoglobulin isotype
DE50011030D1 (de) Verfahren zur chromatographischen fraktionierung von plasma oder serum, so erhaltene präparate und deren verwendung
FI20095269A (fi) Lymfosyyttien sitoutumiseen vaikuttava ihmisen endoteelisolun molekyyli
HUP9903789A2 (hu) von Willebrand-faktor származék, valamint eljárás proteinek izolálására
GR970300022T1 (en) Peptide capable of being recognised by antibodies recognising the C33 antigen of hepatitis C virus
HU9203635D0 (en) Method for producing antigene specifical human monoclonal antibodies of high affinity
SE7904276L (sv) Renat cancerassocierat protein
RU95120418A (ru) Способ получения альфа-фетопротеина
ES2148248T3 (es) Peptidos de la lipoproteina (a) y su utilizacion.
IT1247534B (it) Anticorpo nl07 e relativo procedimento di produzione
WO1998056822A3 (en) Process for the separation of specific immunoglobulins from standard plasma